Amino-terminal fragment of urokinase-type plasminogen activator inhibits HIV-1 replication

被引:26
作者
Wada, M
Wada, NA
Shirono, H
Taniguchi, K
Tsuchie, H
Koga, J
机构
[1] JCR Pharmaceut Co Ltd, Lab Bioengn & Res, Nishi Ku, Kobe, Hyogo 6512241, Japan
[2] Eiken Chem Co Ltd, Nasu Labs, Ohtahara, Tochigi 3240036, Japan
[3] Osaka Univ, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan
关键词
HIV; AIDS; CD8; uPA; ATF; uPAR; lipid raft; assembly; budding; GPI-anchored protein;
D O I
10.1006/bbrc.2001.4965
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD8(+) T lymphocytes have been shown to produce unidentified soluble factors active in suppressing HIV-1 replication. In this study, we purified an HIV-1 suppressing activity from the culture supernatant of an immortalized CD8(+) T cell clone, derived from an HIV-1 infected long-term nonprogressor, and identified this activity as the amino-terminal fragment (ATF) of urokinase-type plasminogen activator (uPA), ATF is catalytically inactive, but suppresses the release of viral particles from the HIV-1 infected cell lines via binding to its receptor CD87, In contrast, cell proliferation and the secretion of an HIV-1 LTR driven reporter gene product were not affected by ATF. These findings suggest that ATF may inhibit the assembly and budding of HIV-1, which provides a novel therapeutic strategy for AIDS. (C) 2001 Academic Press.
引用
收藏
页码:346 / 351
页数:6
相关论文
共 28 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]  
BALER M, 1995, NATURE, V378, P563
[3]   CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor [J].
Barker, E .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 :S485-S488
[4]   DISTINCT MODES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRAL LATENCY REVEALED BY SUPERINFECTION OF NONPRODUCTIVELY INFECTED CELL-LINES WITH RECOMBINANT LUCIFERASE-ENCODING VIRUSES [J].
CHEN, BK ;
SAKSELA, K ;
ANDINO, R ;
BALTIMORE, D .
JOURNAL OF VIROLOGY, 1994, 68 (02) :654-660
[5]  
CHEN CC, 1993, ASIA PAC J PHARMACOL, V8, P1
[6]   IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS [J].
COCCHI, F ;
DEVICO, AL ;
GARZINODEMO, A ;
ARYA, SK ;
GALLO, RC ;
LUSSO, P .
SCIENCE, 1995, 270 (5243) :1811-1815
[7]   SUPPRESSION OF ACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS LONG TERMINAL REPEAT BY CD8(+) T-CELLS IS NOT LENTIVIRUS SPECIFIC [J].
COPELAND, KFT ;
MCKAY, PJ ;
ROSENTHAL, KL .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (11) :1321-1326
[8]   Chemokines and HIV-1 second receptors - Confluence of two fields generates optimism in AIDS research [J].
DSouza, MP ;
Harden, VA .
NATURE MEDICINE, 1996, 2 (12) :1293-1300
[9]   Host factors and the pathogenesis of HIV-induced disease [J].
Fauci, AS .
NATURE, 1996, 384 (6609) :529-534
[10]   INTERFERENCE WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) REPLICATION BY CD8+ T-CELLS IN PERIPHERAL-BLOOD LEUKOCYTES OF ASYMPTOMATIC HIV CARRIERS INVITRO [J].
KANNAGI, M ;
MASUDA, T ;
HATTORI, T ;
KANOH, T ;
NASU, K ;
YAMAMOTO, N ;
HARADA, S .
JOURNAL OF VIROLOGY, 1990, 64 (07) :3399-3406